CHICAGO--(BUSINESS WIRE)--Tempus AI, Inc. (NASDAQ: TEM), a leader in artificial intelligence and precision medicine, today announced the launch of a new program specifically geared towards using ...
(CN) — Can algorithms improve human decision-making by taking out bias-prone factors like age, race and gender? It’s not a particularly new debate, but it’s one that’s gained renewed attention lately ...
New RNA-based algorithm is now available with the xR assay “This program is truly the intersection of all three of our business units – genomics, AI applications, and data – leveraging our deep ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results